Correlation Between Vitrolife and I Tech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vitrolife and I Tech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vitrolife and I Tech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vitrolife AB and I Tech, you can compare the effects of market volatilities on Vitrolife and I Tech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vitrolife with a short position of I Tech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vitrolife and I Tech.

Diversification Opportunities for Vitrolife and I Tech

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Vitrolife and ITECH is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Vitrolife AB and I Tech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on I Tech and Vitrolife is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vitrolife AB are associated (or correlated) with I Tech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of I Tech has no effect on the direction of Vitrolife i.e., Vitrolife and I Tech go up and down completely randomly.

Pair Corralation between Vitrolife and I Tech

Assuming the 90 days trading horizon Vitrolife AB is expected to under-perform the I Tech. But the stock apears to be less risky and, when comparing its historical volatility, Vitrolife AB is 1.04 times less risky than I Tech. The stock trades about -0.04 of its potential returns per unit of risk. The I Tech is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest  7,899  in I Tech on April 21, 2025 and sell it today you would earn a total of  3,451  from holding I Tech or generate 43.69% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Vitrolife AB  vs.  I Tech

 Performance 
       Timeline  
Vitrolife AB 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Vitrolife AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Vitrolife is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
I Tech 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in I Tech are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, I Tech unveiled solid returns over the last few months and may actually be approaching a breakup point.

Vitrolife and I Tech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vitrolife and I Tech

The main advantage of trading using opposite Vitrolife and I Tech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vitrolife position performs unexpectedly, I Tech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in I Tech will offset losses from the drop in I Tech's long position.
The idea behind Vitrolife AB and I Tech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments